Neuro-Oncology Reviews
Volume
26 Number 22
10 October 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 22, 10 October
Bhardwaj JS, Paliwal S, Singhvi G, Taliyan R.
Immunological
challenges and opportunities in glioblastoma multiforme: A
comprehensive view from immune system lens.
Life
Sci. 2024 Oct 1;357:123089. doi:
10.1016/j.lfs.2024.123089. PMID:
39362586. Review˰ ˍ
Okon II, Osama M, Akpan A, Fabrini Paleare LF, Ferreira MY,
Shafqat MD, Razouqi Y, James E, Omer M, Ja'afar IK, Chaurasia B,
Iqbal M, Balogun S, Maidan A, Hussain Jakhar MO, Precious FK,
Gbayisomore TJ, Lucero-Prisno DE 3rd.
The
Evolving Role of Palliative Care in older people with
Glioblastoma.
World
Neurosurg. 2024 Oct 1:S1878-8750(24)01674-7. doi:
10.1016/j.wneu.2024.09.125. PMID:
39362596. Review˰ ˍ
*Alnahhas I.
Molecular Testing in
Gliomas: What is Necessary in Routine Clinical Practice?
Curr
Oncol Rep. 2024 Oct 3. doi:
10.1007/s11912-024-01602-w. PMID:
39361075. Review. ˍ
**Magnon C.
What a wonderful world!
Genes
Dev. 2024 Oct 3;38(17-20):802-804. doi:
10.1101/gad.352278.124. PMID:
39362781. Meeting report. ˍ
Vatankhah A, Moghaddam SH, Afshari S, Afshari AR, Kesharwani P,
Sahebkar A.
Recent update on anti-tumor
mechanisms of valproic acid in glioblastoma multiforme.
Pathol
Res Pract. 2024 Oct 3;263:155636. doi:
10.1016/j.prp.2024.155636. PMID:
39395298. Review˰ ˍ
Bourbonne V, Ollivier L, Antoni D, Pradier O, Cailleteau A, Schick
U, Noël G, Lucia F.
Diagnosis and
management of brain radiation necrosis.
Cancer
Radiother. 2024 Oct 4:S1278-3218(24)00141-0. doi:
10.1016/j.canrad.2024.07.014. PMID:
39366819. Review˰ ˍ
Epstein JE, Pople CB, Meng Y, Lipsman N.
An
update on the role of focused ultrasound in neuro-oncology.
Curr
Opin Neurol. 2024 Oct 4;37(6):682-692. doi:
10.1097/WCO.0000000000001314. PMID:
39498847. Review. ˍ
Jelski W, Mroczko B.
MicroRNAs as
Biomarkers of Brain Tumor.
Cancer
Manag Res. 2024 Oct 4;16:1353-1361. doi:
10.2147/CMAR.S484158. PMID:
39380890. Review. ˍ
Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I,
Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar
A.
Personalized mRNA vaccines in
glioblastoma therapy: from rational design to clinical trials.
J
Nanobiotechnology. 2024 Oct 4;22(1):601. doi:
10.1186/s12951-024-02882-x. PMID:
39367418. Review. ˍ
Cui J, Zou X, Han Y, Jiang J.
Benign
extracranial meningioma with pulmonary metastasis: a case report
and review of literature.
J
Med Case Rep. 2024 Oct 5;18(1):461. doi:
10.1186/s13256-024-04800-z. PMID:
39367495. Case report; Review. ˍ
Jiwei B, Abulimiti M, Yonglong J, Jie W, Shuyan Z, Chao L, Zishen
W, Wei W, Yinuo L, Weiwei W, Lu Y, Shimizu S.
Proton
beam therapy in a patient with secondary glioblastoma (32 years
after postoperative irradiation of medulloblastoma): case report
and literature review.
Radiat
Oncol. 2024 Oct 5;19(1):136. doi:
10.1186/s13014-024-02515-5. PMID:
39369243. Case report; Review. ˍ
Wen PY, Preusser M, Albert NL.
Design
and conduct of theranostic trials in neuro-oncology: Challenges
and opportunities.
Neuro
Oncol. 2024 Oct 5:noae162. doi:
10.1093/neuonc/noae162. PMID:
39368109. Review. ˍ
Pucko E, Sulejczak D, Ostrowski RP.
Subependymal
Giant Cell Astrocytoma: The Molecular Landscape and Treatment
Advances.
Cancers
(Basel). 2024 Oct 7;16(19):3406. doi:
10.3390/cancers16193406. PMID:
39410026. Review. ˍ
Rodriguez SMB, Tataranu LG, Kamel A, Turliuc S, Rizea RE, Dricu
A.
Glioblastoma and Immune Checkpoint
Inhibitors: A Glance at Available Treatment Options and Future
Directions.
Int
J Mol Sci. 2024 Oct 7;25(19):10765. doi:
10.3390/ijms251910765. PMID:
39409094. Review. ˍ
Bennebroek CA, Montauban van Swijndregt MC, van Zwol J, Bhusal S,
Dittrich AT, Oostenbrink R, Pott JWR, Buijs EA, Schouten-van
Meeteren AY, Porro GL, de Graaf P, Saeed P.
Treatment
of isolated pediatric optic nerve glioma: A nationwide
retrospective cohort study and systematic literature review on
visual and radiological outcome.
Pediatr
Blood Cancer. 2024 Oct 8:e31358. doi:
10.1002/pbc.31358. PMID:
39380191. Observational study; Review. ˍ
Levine AB, Hawkins CE.
Molecular
markers for pediatric low-grade glioma.
Childs
Nerv Syst. 2024 Oct 8. doi:
10.1007/s00381-024-06639-7. PMID:
39379532. Review˰ ˍ
Lim-Fat MJ, Roberto K, Wen PY.
Clinical
trial design for novel targeted agents in neuro-oncology.
J
Neurooncol. 2024 Oct 8. doi:
10.1007/s11060-024-04846-5. PMID:
39377992. Review˰ ˍ
Rathi A, Choudhari AK, Chatterjee A, Sahay A, Bhattacharya K, Sahu
A, Puranik AD, Shah A, Dasgupta A, Gupta T, Epari S.
Spinal
Diffuse Midline Glioma H3K27M-Altered:
Report of a Rare Tumor with Extracranial Skeletal Metastases and
Review of Literature.
Int
J Surg Pathol. 2024 Oct 8:10668969241286243. doi:
10.1177/10668969241286243. PMID:
39376094. Case report; Review˰
ˍ
Ronsley R, Cole B, Ketterl T, Wright J, Ermoian R, Hoffman LM,
Margol AS, Leary SES.
Pediatric
Central Nervous System Embryonal Tumors: Presentation, Diagnosis,
Therapeutic Strategies, and Survivorship-A Review.
Pediatr
Neurol. 2024 Oct 9;161:237-246. doi:
10.1016/j.pediatrneurol.2024.09.031. PMID:
39447443. Review˰ ˍ
*Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K.
Exploring
miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing
frontiers in glioblastoma stem cell targeting.
Naunyn
Schmiedebergs Arch Pharmacol. 2024 Oct 9. doi:
10.1007/s00210-024-03479-9. PMID:
39382681. Review˰ ˍ
Song KW, Scott BJ.
CAR T-cell therapy
for gliomas.
Curr
Opin Neurol. 2024 Oct 9;37(6):672-681. doi:
10.1097/WCO.0000000000001318. PMID:
39498846. Review. ˍ
Stormezand GN, de Meyer E, Koopmans KP, Brouwers AH, Luurtsema G,
Dierckx RAJO.
Update on the Role of
[18F]FDOPA
PET/CT.
Semin
Nucl Med. 2024 Oct 9:S0001-2998(24)00080-1. doi:
10.1053/j.semnuclmed.2024.09.004. PMID:
39384519. Review. ˍ
Renard S, Parent L, de Marzi L, Tsoutsou P, Kirova Y.
Electron
radiation therapy: Back to the future?
Cancer
Radiother. 2024 Oct 10:S1278-3218(24)00140-9. doi:
10.1016/j.canrad.2024.07.013. PMID:
39389842. Review. ˍ
*van den Bent MJ, Franceschi E, Touat M, French PJ, Idbaih A,
Lombardi G, Rudà R, Schweizer L, Capper D, Sanson M,
Wesseling P, Weller M, Eoli M, Anghileri E, Bielle F, Euskirchen
P, Geurts M, Wen PY, Preusser M.
Updated
EANO guideline on rational molecular testing of gliomas,
glioneuronal, and neuronal tumors in adults for targeted therapy
selection - Update 1.
Neuro
Oncol. 2024 Oct 10:noae213. doi:
10.1093/neuonc/noae213. PMID:
39387386. Guidelines. ˍ